Code | 02760 | ||||||||||
MA number | 56/0933/10-S | ||||||||||
Product Form: | plu igf 1x22,5 mg+1x2 ml disp.prostr.(liek.inj.skl.+amp.skl.+blis.1 str.inj.+2 ihly) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | Ipsen Pharma, France | ||||||||||
Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 48 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 16.12.2010 |
SPC: | SPC_Diphereline S.R. 22,5 mg_10_2023.pdf |
PIL: | PIL_Diphereline 22.5mg_10_2023.pdf |
Safety feature | Yes |
Data update: | 03.10.2023 |